Mar 02, 2016
Jordan Shlain MD, ex-Senior Medical Advisor at Optum Global Solutions joins MI7 Medical Advisory Board

AUSTIN, TX - MI7, the Austin-based medical intelligence services company, announced today that Jordan Shlain, MD, Managing Partner of Private Medical, Founder of Healthloop and Medical Advisor at the Center for Professional Development & Entrepreneurship at MD Anderson Cancer Center has joined the company as a member of the Medical Advisory Board.

Dr. Shlain has a vast background of practicing medicine and solving some of the most pressing challenges in the healthcare industry. He has deep understanding of the industry where he served as senior Medical Advisor at Optum Global Solutions while simultaneously participating as a board member in The Hope Street Group, a Washington DC based, bipartisan think tank with a health policy focus.

"Having started as a physician first, Jordan brings a tremendous dedication to helping the healthcare industry, " said Zac Jiwa, CEO of MI7. He added "He will be helping guide MI7's efforts to become the industry-standard integration method that application companies use with electronic health records."

"Q" has integrated with the industry's top EHR systems and integration engines, which allows it to be a turnkey solution for application developers. Companies that use "Q" can quickly turn up hospitals, doctors offices, and clinics around the country. More information about "Q" can be found at http://mi7.io/Q.

About MI7
We connect digital health apps to patient data. MI7's universal API, called "Q" - provides a direct connection to patient information in clinical data systems. "Q" is unique in its simplicity of implementation, affordability, and technology model that magically converts HL7 to JSON, freeing app developers from the need of a data integration engine or highly-trained and expensive HL7 staff. Simply put, MI7 makes it easy to build and deploy health care apps. "Q" - the health data liberation tool of choice for the top digital health apps in the market. Learn more at mi7.io/Q.

Press Contact:
press@mi7.io
(512) 553-5557